Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04360200

Cognitive Impairment in Ageing People

Cognitive Impairment in Ageing People: A Longitudinal Observational Prospective Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Yamei Tang · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

Mild cognitive impairment (MCI) and neurocognitive disorder such as Alzheimer's disease (AD) and Vascular dementia (VaD) have become common diseases in the elderly. The burden of dementia is rising in China, with major medical, social and economic impacts. To address this important public health problem, cohort study on elderly cognitive disorders should be carry out. The methods of early prevention, early diagnosis and early treatment the cognitive disorders in elderly should be found to reduce the burden of the social and economic issue due to dementia. At present, the international corresponding guidelines have taken gene and brain imaging biomarkers as important indicators of dementia pathogenesis research, accurate diagnosis and targeted intervention. The study will construct a prospective cohort to establish database that provide not only comprehensive epidemiological data on the MCI and neurocognitive disorder in ageing people, but also complete the construction of biological samples bank and clinical diagnosis and treatment information database. Using the database, the study will identify the conversion rates from MCI to dementia and risk factors for the progression from MCI to dementia or AD. The study will also apply and develop brain structural and pathological imaging technology to support precision diagnosis of senile cognitive disorders. The study have goals to identify and validate imaging and blood/CSF biomarkers for the early detection and tracking of cognitive disorders.

Conditions

Timeline

Start date
2020-04-01
Primary completion
2040-12-01
Completion
2040-12-01
First posted
2020-04-24
Last updated
2020-09-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04360200. Inclusion in this directory is not an endorsement.